Arcturus Therapeutics Holdings Stock Story
| ARCT Stock | USD 27.93 0.87 3.22% |
Slightly above 70 percent of all Arcturus Therapeutics' private investors are curious in acquiring. The analysis of the overall investor sentiment regarding Arcturus Therapeutics Holdings suggests that a large number of traders are confidant. Arcturus Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Arcturus Therapeutics Holdings. The current market sentiment, together with Arcturus Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Arcturus Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Arcturus Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Arcturus daily returns and investor perception about the current price of Arcturus Therapeutics Holdings as well as its diversification or hedging effects on your existing portfolios.
Arcturus |
Requested story not found. it has been either deleted or moved. View all stories for Arcturus Therapeutics Holdings.
Arcturus Therapeutics Latest Timeline
Arcturus Therapeutics is listed for 27.93. About 91.0% of the company shares are held by institutions such as insurance companies. The book value of Arcturus Therapeutics was presently reported as 10.38. The company has Price/Earnings (P/E) ratio of 119.5. Arcturus Therapeutics recorded a loss per share of 1.12. The entity last dividend was issued on the 16th of November 2017. The firm had 1:7 split on the 16th of November 2017.Check out Arcturus Therapeutics Hype Analysis, Arcturus Therapeutics Correlation and Arcturus Therapeutics Performance. Note that the Arcturus Therapeutics information on this page should be used as a complementary analysis to other Arcturus Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Arcturus Stock analysis
When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Arcturus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcturus Therapeutics. If investors know Arcturus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcturus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 6.264 | Quarterly Revenue Growth (0.81) | Return On Assets (0.11) | Return On Equity (0.11) |
The market value of Arcturus Therapeutics is measured differently than its book value, which is the value of Arcturus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcturus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Arcturus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcturus Therapeutics' market value can be influenced by many factors that don't directly affect Arcturus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcturus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcturus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcturus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.